Boston, MA -- (SBWIRE) -- 06/07/2013 -- Kenya is an attractive prospect for companies looking to set up a manufacturing base in the region. Among the East African Community (EAC), Kenya has the deepest financial markets and an efficient manufacturing sector, as well as being home to the strategically important port of Mombasa. However, we caution there are weaknesses in the business environment, most notably a high level of corruption, which can make it difficult for both local and foreign firms to conduct transparent operations.

Headline Expenditure Projections

- Pharmaceuticals: KES47.37.bn (US$560mn) in 2012 to KES55.36bn (US$620mn) in 2013; 16.9% growth in local currency terms and 11.8% in US dollar terms.
- Healthcare: KES149.71bn (US$ 1.77bn) in 2012 to KES168.06bn (US$1.88bn) in 2013; 12.3% growth in local currency terms and 6.0% in US dollar terms.

View Full Report Details and Table of Contents

Risk/Reward Rating: In BMI's Q313 Pharmaceutical and Healthcare Risk/Reward Ratings (RRRs), Kenya is 20th in the Middle East and Africa (MEA), above Uganda, Nigeria and Zambia. A large counterfeiting industry, poor healthcare funding, corruption, regulatory deficiencies and a number of other issues will conspire to keep Kenya in a low position in the MEA matrix. Nevertheless, in comparison with many other African markets, most of which are not surveyed by BMI, Kenya offers more commercial promise and a more stable overall business environment.

Key Trends And Developments

Kenya's newly elected President Uhuru Kenyatta has pledged to provide universal health care, stating that all health care and dispensaries should be accessible for free and no woman should be charged for having to have her delivery in a public institution.

In April 2013, it was revealed that the government plans to open public health laboratories across the country, which will be implemented by the Ministry of Public Health and Sanitation. The laboratories will be built as part of a KES2bn (US$22.90mn) World Bank-funded East Africa public health laboratory networking project and will help in tracking communicable diseases throughout the nation. The national public health laboratory in Nairobi will also be revamped under the project, which itself is part of a larger KES5.6bn (US$64.13bn) World Bank project aimed at developing a network of diagnostic laboratories across East Africa for the surveillance of tuberculosis and other communicable diseases.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:

- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals
- Partnerships, Licensing, Investments and M&A Deals and Trends for January 2013 in Pharmaceuticals
- Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2012
- Bayer Healthcare Pharmaceuticals - SWOT, Strategy and Corporate Finance Report
- Partnerships, Licensing, Investments and M&A Deals andTrends in Pharmaceuticals - Q2 2012
- Presidio Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Affectis Pharmaceuticals AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Alnylam Pharmaceuticals, Inc (ALNY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Bayer Healthcare LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile